DH091ZZ
Beam Radiation Skin, Buttock to None with None, Photons 1 - 10 MeV Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | H Skin |
| Operation | 0 Beam Radiation |
| Body Part | 9 Skin, Buttock |
| Approach | 1 Photons 1 - 10 MeV |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the skin uses an external machine to aim ionizing radiation, typically low-energy or superficial x-rays or electron beams, directly at a lesion or area on the skin's surface. It is a common treatment for basal cell and squamous cell skin cancers, particularly on the face, scalp, or other areas where surgical removal would be difficult or disfiguring, and it is also used for Kaposi sarcoma lesions, keloid scars, and certain benign but symptomatic skin conditions.
Because the beam can be focused to a shallow depth, it damages the targeted skin cells while limiting exposure to deeper tissue. Treatment is usually delivered in a series of short outpatient sessions over one to several weeks, with the total dose divided into fractions to reduce side effects such as skin redness, dryness, or peeling in the treated area.
Anatomy & Axis Detail
Skin, Buttock
Buttock skin is treated with beam radiation less frequently than other trunk sites, typically for cutaneous malignancy, pressure-related skin cancers, or postsurgical scar management, and the thick subcutaneous tissue and gluteal musculature in this region can require higher beam energies to achieve adequate skin-surface dose without excessive depth penetration. Positioning for treatment often demands attention to patient comfort and skin fold management, since moisture and friction in this area increase the risk of radiation dermatitis during a treatment course. Because buttock lesions may be associated with chronic wounds or pressure injuries in patients with limited mobility, documentation should confirm that radiation is directed at a discrete cutaneous lesion rather than being part of wound management, ensuring accurate application of this code.
Modality Qualifier: Photons 1 - 10 MeV
Photons 1 to 10 MeV identifies radiation therapy delivered using megavoltage photon beams in this energy range, the standard produced by most modern linear accelerators for treating deeper tumors with better skin sparing and dose distribution than lower-energy beams. It is distinguished from the sub-1 MeV range used for superficial treatment and represents the energy band applied to the majority of external beam courses.
Coding & Documentation
Coding from this family requires documentation of the specific skin site treated and confirmation that an external beam device, not a topical or implanted source, delivered the radiation. The treatment planning note and daily treatment records should specify the anatomical region, since ICD-10-PCS distinguishes skin sites by general body area rather than by exact lesion location. A common mistake is coding each treatment fraction separately when the payer or facility policy calls for a single code representing the full course, or conversely failing to capture repeat courses when a lesion recurs and is treated again later. Coders should also watch for cases where a dermatologic radiation unit uses superficial or contact-style equipment, which may fall under the Other Radiation qualifier rather than Beam Radiation, so the equipment type documented in the treatment record needs to be checked rather than assumed.
Commonly Confused With
The closest source of confusion is D|H|Y (Other Radiation to the skin), which covers modalities such as contact or plesiotherapy units, superficial isotope applicators, or other non-beam techniques; the distinguishing detail is the type of radiation-generating equipment used, found in the radiation oncology treatment plan. It can also be confused with dermatologic procedures coded outside the Radiation Therapy section, such as cryotherapy or laser destruction of skin lesions, which use non-ionizing energy sources and are not radiation therapy at all despite treating similar lesions.
